Temocillin for the treatment of bloodstream infections in critically ill

Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), C. Coltienne, Xavier Wittebole(Cliniques Universitaires Saint-Luc), Diego Castanares Zapatero

Digital Access to Libraries

January 1, 2007

Cited by 0

Related Papers

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

|New England Journal of Medicine|2001|6.1k

High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure

|New England Journal of Medicine|2015|2.4k

Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017

|JAMA|2020|1k

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

|New England Journal of Medicine|2005|890

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis

|JAMA|2013|797